Get Started

Artificial Intelligence | Machine Learning Encellin | Advancing Next Generation Therapies

Consumer, Biotechnology, Therapeutic Evaluation, Therapy Onboarding, Biotech, Chronic Disease Management, Gene San Francisco, California , United States

Artificial Intelligence | Machine Learning

Encellin | Advancing Next Generation Therapies

Biotechnology, Therapeutic Evaluation, Therapy Onboarding, Biotech, Chronic Disease Management, Gene

San Francisco, California , United States

Encellin is focused on advancing next generation therapies, starting with endocrine disorders. We are developing a minimally invasive implant delivering therapeutics where needed. Our technology and patient-driven approach combines functional cell therapies with a novel cell encapsulation technology with to treat chronic diseases.

Total Funding: N/A

Funding Stage: N/A

Business Stage: Scaling Up

Market: B2C

Company Size: 1 to 25

Founded: 2016

Date

Round

$ Raised

Investors

08/05/2021

Seed

$5.9M

Y Combinator, SV Latam Capital, Sand Hill Angels, Khosla Ventures

Date : 08/05/2021

Round: Seed

$ Raised: $5.9M

Investors: Y Combinator, SV Latam Capital, Sand Hill Angels, Khosla Ventures

For AI/ML Startup Founders

Get introduced to VC/PE/CVC investors

Signup and Get Started

For Investors at VC/PE firms

Get introduced to AI/ML Startup founders or founders at Encellin

Crystal Nyitray
CEO/Founder

Grace Wei
COO/Founder

Ronald Martell
President & CEO, Director

Robert Tucker
Director of Engineering

Ian Welch
Business Development

James Peterman
Associate Preclincal Engineer

Encellin - Manage Profile

Encellin is growing. Want to work at Encellin? Encellin is hiring. Join team at Encellin

World's Most Promising AI/ML Startups